161 related articles for article (PubMed ID: 35301367)
1. Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1
Shapiro D; Massopust R; Taetzsch T; Valdez G
Sci Rep; 2022 Mar; 12(1):4630. PubMed ID: 35301367
[TBL] [Abstract][Full Text] [Related]
2. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
Martineau É; Arbour D; Vallée J; Robitaille R
J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
[TBL] [Abstract][Full Text] [Related]
3. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
4. The role of muscle microRNAs in repairing the neuromuscular junction.
Valdez G; Heyer MP; Feng G; Sanes JR
PLoS One; 2014; 9(3):e93140. PubMed ID: 24664281
[TBL] [Abstract][Full Text] [Related]
5. Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS.
Taetzsch T; Tenga MJ; Valdez G
J Neurosci; 2017 Jan; 37(1):70-82. PubMed ID: 28053031
[TBL] [Abstract][Full Text] [Related]
6. VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions.
Sugita S; Fleming LL; Wood C; Vaughan SK; Gomes MP; Camargo W; Naves LA; Prado VF; Prado MA; Guatimosim C; Valdez G
Skelet Muscle; 2016; 6():31. PubMed ID: 27713817
[TBL] [Abstract][Full Text] [Related]
7. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
Rocha MC; Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
PLoS One; 2013; 8(9):e73846. PubMed ID: 24040091
[TBL] [Abstract][Full Text] [Related]
8. Muscle Expression of SOD1
Dobrowolny G; Martini M; Scicchitano BM; Romanello V; Boncompagni S; Nicoletti C; Pietrangelo L; De Panfilis S; Catizone A; Bouchè M; Sandri M; Rudolf R; Protasi F; Musarò A
Antioxid Redox Signal; 2018 Apr; 28(12):1105-1119. PubMed ID: 28931313
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
10. KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice.
Massopust R; Juros D; Shapiro D; Lopes M; Haldar SM; Taetzsch T; Valdez G
Neurobiol Dis; 2022 Jan; 162():105583. PubMed ID: 34902552
[TBL] [Abstract][Full Text] [Related]
11. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
12. Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis.
Rizzuto E; Pisu S; Musarò A; Del Prete Z
Ann Biomed Eng; 2015 Sep; 43(9):2196-206. PubMed ID: 25631208
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis.
Tallon C; Sharma A; Zhang Z; Thomas AG; Ng J; Zhu X; Donoghue A; Schulte M; Joe TR; Kambhampati SP; Sharma R; Liaw K; Kannan S; Kannan RM; Slusher BS
Neurotherapeutics; 2022 Jan; 19(1):274-288. PubMed ID: 34984651
[TBL] [Abstract][Full Text] [Related]
14. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
Gordon T; Tyreman N; Li S; Putman CT; Hegedus J
Neurobiol Dis; 2010 Feb; 37(2):412-22. PubMed ID: 19879358
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
16. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
17. Functional adaptation of glial cells at neuromuscular junctions in response to injury.
Perez-Gonzalez AP; Provost F; Rousse I; Piovesana R; Benzina O; Darabid H; Lamoureux B; Wang YS; Arbour D; Robitaille R
Glia; 2022 Sep; 70(9):1605-1629. PubMed ID: 35474470
[TBL] [Abstract][Full Text] [Related]
18. Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALS.
Rozas P; Pinto C; Martínez Traub F; Díaz R; Pérez V; Becerra D; Ojeda P; Ojeda J; Wright MT; Mella J; Plate L; Henríquez JP; Hetz C; Medinas DB
Acta Neuropathol Commun; 2021 Feb; 9(1):21. PubMed ID: 33541434
[TBL] [Abstract][Full Text] [Related]
19. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis.
Hegedus J; Putman CT; Tyreman N; Gordon T
J Physiol; 2008 Jul; 586(14):3337-51. PubMed ID: 18467368
[TBL] [Abstract][Full Text] [Related]
20. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
